Clinical Trials Browser

Completed × Multiple Sclerosis × nabiximols × Clear all

NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia